After Two Years of Legislative Stalls, Largest Pharmacy Benefit Managers Facing Questions on Nation’s Drug Prices

It’s a question echoed throughout every corner of the United States: Why are prescription drug prices so high?
A Congressional committee is aiming to find out.
Rep. James Comer (R-Ky.) announced a formal investigation on March 1 after more than two years of legislative attempts to demand transparency and accountability from the nation’s largest pharmacy benefit managers (PBMs).
Comer, the House Oversight and Accountability Committee chairman, sent letters to the country’s three largest PBMs on March 1, including Cigna Express Scripts, CVS Caremark, and UnitedHealth Group’s Optum Rx.
In his communication, Comer noted those three companies alone control 80 percent of the PBM market….